Genomic rearrangements involving the RSPO2 and RSPO3 genes have been found to provide an alternative mechanism of aberrant WNT pathway activation in CRC (Seshagiri et al, 2012). The gene discussed is RSPO3; the disease is colorectal carcinoma.